Correlation between lipid profile and rapid virological response to treatment of hepatitis C virus genotype IV with pegylated interferon alpha and ribavirin

Studying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment

Studying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment

Aetiology of anemia in chronic HCV patients receiving pegylated interferon plus ribavirin

Changes in immunomodulators in relation to interferon therapy in hepatitis c virus infection

The effect of dual therapy of pegylated interferon and ribavirin on viral load and liver enzymes of hepatitis c patients

Diabetic chronic HCV patients and their response to interferon therapy

Evaluation of the risk of atherosclerosis in chronic hepatitis C patients

Effect Of DBD alone and incombination with amantadinehydrochloride and Ribavirin In patients with chronic HCV

Changes in chemokines levels in relation to combined interferon and ribavirin therapy in Egyptian patients with chronic hepatitis C